Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin
October 04, 2022 07:30 ET
|
Innovation Pharmaceuticals Inc
In pre-clinical studies, Brilacidin shown to synergize with marketed antifungals against pathogenic species of aspergillosis, candidiasis, cryptococcosis and mucormycosis, and further exhibited...